Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
Rose, P. G., Drake, R., Braly, P. S., Bell, M. C., Wenham, R. M., Hines, J. H., Alvarez-Secord, A., Soltes-Rak, E., Childs, B. H., Herzog, T. J.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Preliminary safety and efficacy results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
Herzog, T. J., Spirtos, N. M., Hines, J. F., Braly, P. S., Bell, M., Secord, A. A., Rose, P., Monk, B. J., Soltes-Rak, E., Childs, B. H.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Factors regulating cryIVB expression in the cyanobacterium Synechococcus PCC 7942
Soltes-Rak, E, Kushner, D.J, Williams, D.D, Coleman, J. (Toronto Univ. (Canada). Centre for Plant Biotechnology. Dept. of Botany)
Published in Molecular & general genetics (01.05.1995)
Published in Molecular & general genetics (01.05.1995)
Get more information
Journal Article